https://www.marketscreener.com/quote/stock/ALLOGENE-THERAPEUTICS-INC-46536033/news/Allogene-Therapeutics-Inc-Announces-Oral-Presentation-of-Phase-1-Data-on-ALLO-316-At-the-American-43249040/?utm_source=telegram&utm_medium=social&utm_campaign=share